Search company, investor...

CuraGen

curagen.com

Founded Year

1991

Stage

Acq - P2P | Acquired

Total Raised

$39.29M

Valuation

$0000 

About CuraGen

CuraGen is a Healthcare/Biotechnology company based in Branford, Connecticut. CuraGen's investors include Cooper Hill Partners and Soros Fund Management.

Headquarters Location

322 East Main Street

Branford, Connecticut, 06405,

United States

203-481-1104

Missing: CuraGen's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: CuraGen's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing CuraGen

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CuraGen is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CuraGen Patents

CuraGen has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/26/2014

5/14/2019

Glucocorticoids, Oncology, Antineoplastic drugs, Experimental cancer drugs, Cancer treatments

Grant

Application Date

11/26/2014

Grant Date

5/14/2019

Title

Related Topics

Glucocorticoids, Oncology, Antineoplastic drugs, Experimental cancer drugs, Cancer treatments

Status

Grant

Latest CuraGen News

Clovis Oncology adds former Pfizer VP to board

Jul 13, 2021

BOULDER — Clovis Oncology (NYSE: CLVS) is increasing the number of directors on its board from 10 to 11 and filling that vacancy with Dr. Ronit Simantov, the company announced Monday in a news release. Simantov is the chief medical officer at the cell-therapy company Gamida Cell Ltd. She had previously served as vice president for oncology global medical affairs at Pfizer Inc, with other experience at OSI Pharmaceuticals, CuraGen Corporation and Bayer HealthCare Pharmaceuticals. Simantov will receive $55,000 in annual cash retainers for her role on the board. She will also receive a one-time option to purchase 83,212 shares of Clovis Oncology stock. © 2021 BizWest Media LLC BOULDER — Clovis Oncology (NYSE: CLVS) is increasing the number of directors on its board from 10 to 11 and filling that vacancy with Dr. Ronit Simantov, the company announced Monday in a news release. Simantov is the chief medical officer at the cell-therapy company Gamida Cell Ltd. She had previously served as vice president for oncology global medical affairs at Pfizer Inc, with other experience at OSI Pharmaceuticals, CuraGen Corporation and Bayer HealthCare Pharmaceuticals. Simantov will receive $55,000 in annual cash retainers for her role on the board. She will also receive a one-time option to purchase 83,212 shares of Clovis Oncology stock. © 2021 BizWest Media LLC

CuraGen Frequently Asked Questions (FAQ)

  • When was CuraGen founded?

    CuraGen was founded in 1991.

  • Where is CuraGen's headquarters?

    CuraGen's headquarters is located at 322 East Main Street, Branford.

  • What is CuraGen's latest funding round?

    CuraGen's latest funding round is Acq - P2P.

  • How much did CuraGen raise?

    CuraGen raised a total of $39.29M.

  • Who are the investors of CuraGen?

    Investors of CuraGen include Celldex Therapeutics, Cooper Hill Partners, Soros Fund Management and Pequot Venture Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.